Clinical Efficacy of Prothrombin Complex Concentrates and Recombinant Factor VIIa in the Treatment of Bleeding Episodes in Patients with Factor VIII and IX Inhibitors-Reference-Cited by-同舟云学术

Clinical Efficacy of Prothrombin Complex Concentrates and Recombinant Factor VIIa in the Treatment of Bleeding Episodes in Patients with Factor VIII and IX Inhibitors

Published:1999-08 Issue:4 Volume:95 Page:S31-S38
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Barthels Monika

Publisher

Elsevier BV

Subject

Hematology

Reference74 articles.

1. Prothrombin concentrates in treatment of Christmas disease and allied disorders;Breen;JAMA,1969

2. Fekete LF, Holst SL, Peetom F, Deveber LL. Auto-factor IX concentrate: A new therapeutic approach to treatment of haemophilia A patients with inhibitors. 14th Intern. Congress of Hematology. Brazil, 1972, A295.

3. Activated prothrombin concentrate for patients with factor VIII inhibitors;Kurczynsky;N Engl J Med,1974

4. Factor VIII inhibitor by-passing activity (FEIBA) in the management of patients with factor VIII inhibitors;Preston;Thromb Res,1977

5. Effect of in vivo administration of FEIBA on clotting tests. Dose-response relationship;Nowotny;Thromb Haemost,1979

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Budget impact and cost-utility analysis of prophylactic emicizumab versus on-demand bypassing agents for adolescent severe haemophilia A patients with inhibitors in India;Heliyon;2024-03

2. Cost‐effectiveness of emicizumab vs bypassing agents in the prevention of bleeding episodes in haemophilia A patients with anti‐FVIII inhibitors in France;Haemophilia;2020-11-18

3. Prothrombin complex concentrate;Meyler's Side Effects of Drugs;2016

4. Factor VII;Meyler's Side Effects of Drugs;2016

5. Factor VIII and IX Inhibitors in Hemophilia;Hemostasis and Thrombosis;2014-02-14